JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Treatment of the Chiari malformation with bone decompression without durotomy in children and young adults.

OBJECTIVE: The purpose of this study was to provide more information on alternative operative approaches to the treatment of symptomatic Chiari type I and/or type II malformations in children and young adults.

METHODS: All patients were treated with craniocervical decompression without durotomy or duroplasty. The cervical decompression was carried on to the lowest level of tonsillar herniation.

CONCLUSIONS: In 22 patients with symptomatic Chiari type I (4) and/or Chiari type II (18) malformation, there was total improvement in 12, partial improvement in 7, and no change in 3. There was no operative morbidity or mortality. Craniocervical decompression without durotomy may be a suitable treatment modality for symptomatic Chiari malformation in children and young adults.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app